Renal Denervation Devices Market to Reach US$4.27 Billion by 2036 as Minimally Invasive Hypertension Treatment Gains Momentum
Renal denervation (RDN) devices are minimally invasive medical technologies designed to reduce excessive sympathetic nerve activity surrounding the renal arteries. Using catheter-based energy delivery, these systems target renal nerves involved in blood-pressure regulation. The procedure is primarily being developed and adopted as an additional treatment option for patients with uncontrolled or...
0 Комментарии
0 Поделились